CAR-T therapy utilizing Oncostatin-M ligand demonstrates significant anti-tumor efficacy in osteosarcoma treatment - Quiz - MDSpire

CAR-T therapy utilizing Oncostatin-M ligand demonstrates significant anti-tumor efficacy in osteosarcoma treatment

  • By

  • Daniel Feinberg

  • Vinayak Uppin

  • Saada Eid

  • Claire Fritz

  • Masahiro Hitomi

  • Akshaya Radhakrishnan

  • Kayla Klatt

  • Sung Hee Choi

  • Jay T Myers

  • Aarshvi Bhatt

  • Duncan Stearns

  • Irina Pateva

  • Zachary D C Burke

  • Alex Y Huang

  • Gary K Schwartz

  • Reshmi Parameswaran

  • March 17, 2026

  • 0 min

Share

Original Source(s)

CAR-T therapy utilizing Oncostatin-M ligand demonstrates significant anti-tumor efficacy in osteosarcoma treatment

  • by Daniel Feinberg, Vinayak Uppin, Saada Eid, Claire Fritz, Masahiro Hitomi, Akshaya Radhakrishnan, Kayla Klatt, Sung Hee Choi, Jay T Myers, Aarshvi Bhatt, Duncan Stearns, Irina Pateva, Zachary D C Burke, Alex Y Huang, Gary K Schwartz, Reshmi Parameswaran

  • March 17, 2026

Related Content

Case Report: Dynamic TKI combination strategies for EGFR-mutant NSCLC with acquired ROS1 fusion and brain metastases

Case Report: Zoledronic acid-induced hyperprogression in oncology: a case study of RET-driven neuroendocrine carcinoma treated with Selpercatinib

Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk